Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New study evaluates GTI-2040 plus gemcitabine for solid tumors

Feb. 12, 2004

German scientists present proapoptotic IAP modulators for use in cancer therapy

Feb. 12, 2004

ProtoKinetix obtains option to license mammastatin-based products

Feb. 12, 2004

Update on single-agent Triapine phase II trials

Feb. 11, 2004

Genasense NDA accepted for review

Feb. 11, 2004

Nippon Kayaku claims a novel antineoplastic antibiotic from Streptomyces sp.

Feb. 11, 2004

Pharmacia scientists report novel telomerase inhibitors in a recent patent

Feb. 11, 2004

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...